Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

kneat.com Inc. (V:KSI)

Business Focus: Enterprise Software

Jul 19, 2021 04:59 pm ET
Leading Global Healthcare Brand Selects Kneat's SaaS Platform
LIMERICK, Ireland, July 19, 2021 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") is pleased to announce it has signed a three-year Master Services Agreement to be the corporate enterprise e-validation solution for one of the world's leading healthcare brands.
Jun 02, 2021 05:23 pm ET
Global Engineering Leader Selects Kneat's SaaS Platform
LIMERICK, Ireland, June 2, 2021 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a three-year Master Services Agreement with one of the world's leading engineering, consultancy and design firms to digitize Commissioning, Qualification and Validation services to both their food and life sciences clients. 
May 25, 2021 06:45 pm ET
Kneat Reports 2021 First Quarter Results
Q1 Revenues of $2.35 million, up 147% year-over-year
May 21, 2021 12:04 pm ET
Kneat Announces New Director, New Omnibus Plan, and Release Date Q1 Results
LIMERICK, Ireland, May 21, 2021 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat or the company") is pleased to announce the election of accomplished executive, Mrs. Nutan Behki, to its Board of Directors, the adoption of its new Omnibus Equity Incentive Plan, and the release date for the company's first quarter financial results.
May 07, 2021 09:53 am ET
Kneat Announces Selection by Top Ten Biopharma as the Corporate Solution for Global Manufacturing and Provides an Update on its Recent Financing
LIMERICK, Ireland, May 7, 2021 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") announces it has signed a five-year corporate Master Services Agreement (MSA) with another top ten biopharma company, and provides an update on its recent financing.  
Apr 28, 2021 09:10 am ET
Kneat Announces Closing of $20,125,575 Public Equity Financing and Concurrent $2,000,000 Non-Brokered Private Placement Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ 
Apr 22, 2021 05:15 pm ET
Kneat Announces New Nominee for Election to Board of Directors
LIMERICK, Ireland, April 22, 2021 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat or the company") is pleased to announce the nomination of accomplished executive, Mrs. Nutan Behki, to stand for election to the company's board of directors at its 2021 annual general meeting, scheduled for May 20, 2021.
Apr 07, 2021 04:46 pm ET
Kneat Announces $17.5 Million Bought Deal Public Offering
 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Mar 26, 2021 07:12 am ET
Global Life Sciences CDMO Selects Kneat's e-Validation SaaS Platform
LIMERICK, Ireland, March 25, 2021 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") - is pleased to announce that it has signed a five-year Master Services Agreement with one of the world's largest contract development and manufacturing organizations (CDMO) to digitize its global Computer System Validation, Commissioning, and Qualification processes.
Mar 10, 2021 04:14 pm ET
E-Validation SaaS Leader Adds Executive Support to Propel Growth
LIMERICK, Ireland, March 10, 2021 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat or the company") is pleased to announce it has appointed accomplished marketing executive, Ms. Laura Sweet, as its Vice President of Marketing.
Feb 23, 2021 05:08 pm ET
Kneat Announces Fiscal 2020 Fourth Quarter and Fiscal Year 2020 Results
2020 Total Revenues of $7.42 million, up 88% Year-over-year Q4 Revenues of $2.96 million, up 112% Year-over-year
Feb 22, 2021 06:05 am ET
Kneat Announces Release Date for Fourth Quarter Financial Results
LIMERICK, Ireland, Feb. 22, 2021 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat"), announces that the Company will release its Financial Results for the quarter ended December 31, 2020 after TSX market close on Tuesday 23 February, 2021. 
Dec 29, 2020 08:28 am ET
First site of Top Ten Biopharma selects Kneat's SaaS Platform
LIMERICK, Ireland, Dec. 29, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat"), a company focused on digitizing and automating Validation processes for Life Sciences, is pleased to announce that it's SaaS platform has been chosen by the first site of another big pharma company. 
Nov 24, 2020 04:28 pm ET
Kneat Reports 2020 Third Quarter Results
LIMERICK, Ireland, Nov. 24, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the period ended September 30, 2020.  All dollar amounts are presented in Canadian dollars unless otherwise stated.
Nov 19, 2020 04:26 am ET
Kneat Announces Release Date for Third Quarter Financial Results
LIMERICK, Ireland, Nov. 19, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat"), announces that the Company will release its Financial Results for the quarter ended September 30, 2020 after TSX market close on Tuesday 24 November, 2020. 
Nov 09, 2020 07:42 am ET
Kneat Appoints Chief Technology Officer
LIMERICK, Ireland, November 9, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat or the company") today announced that it has appointed Mr. Keith Holmes as its Chief Technology Officer effective November 9, 2020.
Aug 26, 2020 05:31 pm ET
Kneat Reports 2020 Second Quarter Results
LIMERICK, Ireland, Aug. 26, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the period ended June 30, 2020.  All dollar amounts are presented in Canadian dollars unless otherwise stated.
Aug 24, 2020 07:05 am ET
August 24, 2020 - Kneat Announces Release Date for Second Quarter Financial Results
LIMERICK, Ireland, Aug. 24, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat"), announces that the Company will release its Financial Results for the quarter ended June 30, 2020 after TSX market close on Wednesday August 26, 2020. 
Aug 05, 2020 09:20 am ET
Leading Consumer Products Company Selects Kneat's SaaS Platform
LIMERICK, Ireland, Aug. 5, 2020 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") is pleased to announce that it has signed a three-year master services agreement with a tier one consumer products company. This agreement may be renewed for additional periods agreed between the parties.
Jun 11, 2020 09:12 am ET
Top Ten Global Biopharma Selects Kneat's SaaS Platform
LIMERICK, Ireland, June 11, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce it has signed a three year master services agreement with one of the world's largest biopharmaceutical companies. The agreement, which has a start date of June 8, 2020 allows this customer to expand Kneat across its global network to its many sites and multiple work processes worldwide.
May 27, 2020 05:18 pm ET
Kneat Reports First Quarter Results
LIMERICK, Ireland, May 27, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the period ended March 31, 2020.  All dollar amounts are presented in Canadian dollars unless otherwise stated.
May 25, 2020 04:56 am ET
Kneat Announces Release Date for First Quarter Financial Results
LIMERICK, Ireland, May 25, 2020 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat"), announces that the Company will release its Financial Results for the quarter ended March 31, 2020 after TSX market close on Wednesday 27 May 2020. 
Apr 22, 2020 06:41 pm ET
Kneat Reports Fourth Quarter Results
LIMERICK, Ireland, April 22, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the quarter and year ended December 31, 2019.  All dollar amounts are presented in Canadian dollars unless otherwise stated.
Apr 20, 2020 08:06 am ET
Kneat Announces Date for 2019 Full Year Financial Results
LIMERICK, Ireland, April 20, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat"), announces that the Company will release its 2019 Full Year Financial Results after TSX market close on Wednesday 22 April 2020.
Mar 25, 2020 08:17 am ET
Top Ten Pharmaceutical Company Selects the Kneat SaaS Platform
LIMERICK, Ireland, March 25, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce it has signed a three-year Software as a Service (SaaS) Master Agreement with another top ten pharmaceutical company.
Mar 24, 2020 10:19 am ET
Kneat Update in Light of COVID-19
LIMERICK, Ireland, March 24, 2020 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") update. COVID-19 is affecting each of us in various ways, and some segments of our society are being hit much harder than others.
Mar 12, 2020 09:39 am ET
Kneat Announces Closing of $12,650,978 Public Equity Financing and Concurrent $1,830,522 Non-Brokered Private Placement Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 27, 2020 09:29 am ET
IIROC Trading Resumption - KSI
VANCOUVER, Feb. 27, 2020 /CNW/ - Trading resumes in:
Feb 27, 2020 08:39 am ET
Kneat Announces $11 Million Overnight Marketed Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 26, 2020 02:34 pm ET
Kneat Announces Overnight Marketed Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 26, 2020 09:07 am ET
IIROC Trading Halt - KSI
VANCOUVER, Feb. 26, 2020 /CNW/ - The following issues have been halted by IIROC:
Feb 06, 2020 08:07 am ET
Global Medical Device Leader Selects Kneat's SaaS Platform
LIMERICK, Ireland, Feb. 6, 2020 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a three-year software as a service ("SaaS") agreement with a top tier medical device company. 
Dec 11, 2019 07:19 am ET
Kneat Signs Global Biopharma Leader
LIMERICK, Ireland, Dec. 11, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a five-year master service agreement with another of the world's leading biopharmaceutical companies.
Nov 26, 2019 04:40 pm ET
Kneat Reports Third Quarter Results
LIMERICK, Ireland, Nov. 26, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the quarter ended September 30, 2019.   All dollar amounts are presented in Canadian dollars unless otherwise stated.
Nov 25, 2019 08:33 am ET
Big Pharma selects Kneat's SaaS Platform for Digitalization of its Validation Work Processes
LIMERICK, Ireland, Nov. 25, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a five-year master service agreement with another one of the worlds largest pharmaceutical companies, to digitalize key validation processes across its manufacturing sites.  Implementation has begun with an expected phase one Go Live on the lead site in Q1 2020.  This agreement allows the customer and its affiliates, with more than 60,000 employees worldwide, to expand Kneat across all its global sites, representing a significant opportunity for growth and expansion of Kne
Sep 20, 2019 08:00 am ET
Kneat Appoints New Chief Financial Officer
LIMERICK, Ireland, Sept. 20, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company") today announced that it has appointed Mr. Hugh Kavanagh as its Chief Financial Officer effective September 23, 2019 following the resignation of Ms. Sarah Oliver who will assist in the transition. Mr. Kavanagh has held senior positions at several multi-national companies in the software and life sciences industries, most recently as Chief Financial Officer of Mainstay Medical during which time he completed an initial public offering and several rounds of funding. He brings strong financial leader
Sep 17, 2019 08:30 am ET
Big Pharma selects Kneat's Commissioning, Qualification and Validation platform
LIMERICK, Ireland, Sept. 17, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it signed a three-year contract with one of the worlds largest pharmaceutical companies to enable digital transformation for its many validation work processes.   This master service agreement allows the customer and its affiliates to expand Kneat Gx across its 100+ global manufacturing sites and represents a significant opportunity for growth and expansion of Kneat's software.
Aug 27, 2019 05:26 pm ET
Kneat Reports Second Quarter Results
LIMERICK, Ireland, Aug. 27, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the quarter ended June 30, 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated.
Jul 22, 2019 07:37 am ET
Global CDMO partners with Kneat to Digitize their Validation work Processes
LIMERICK, Ireland, July 22, 2019 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") is pleased to announce that a global contract development and manufacturing organization ("CDMO") has selected Kneat's platform to digitize their commissioning, qualification and validation work processes. This customer contracted with Kneat for on-premise perpetual licenses on July 12, 2019 and is expected to go live at a European site on multiple processes by the end of the year.  Expansion to all global sites is expected in the future.
Jun 17, 2019 05:52 pm ET
Pioneering Biotech Selects Kneat for its Validation Life Cycle Management
LIMERICK, Ireland, June 17, 2019 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") is pleased to announce that a leading company in the field of messenger RNA ("mRNA") has selected Kneat's software as a service ("SaaS") platform for its validation lifecycle management work processes.  Initially this customer will configure its computer system validation ("CSV") work process on the platform and expand to other validation processes in the future.
Jun 11, 2019 04:49 pm ET
Kneat to provide Corporate Update via webcast on June 19, 2019
LIMERICK, Ireland, June 11, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") announced today that Mr. Eddie Ryan, Chief Executive Officer of Kneat, will provide investors with a corporate update via webcast following the formal portion of its Annual and Special Meeting of shareholders on June 19, 2019 at 10:30AM EST. 
May 28, 2019 08:29 pm ET
Kneat Reports First Quarter Results
HALIFAX, May 28, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the quarter ended March 31, 2019.  All dollar amounts are presented in Canadian dollars unless otherwise stated.
May 01, 2019 05:27 pm ET
Kneat Appoints SaaS Industry Veteran, Rory Cameron, as New Board Member
HALIFAX, May 1, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that Mr. Rory Cameron has been appointed to its Board of Directors.  Mr. Cameron has over 15 years of experience in the software industry and an extensive background in mergers, acquisitions and go-to-market operations within global cloud companies.  Mr. Cameron recently joined Medallia as Executive Vice President, Corporate Development where he is focusing on accelerating Medallia's growth through new technology partnerships and acquisitions.  Prior to joining Medallia, Mr. Cameron was Executive Vice P
Apr 24, 2019 05:40 pm ET
Kneat Reports Fourth Quarter Results
HALIFAX, April 24, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its financial results for the quarter and year ended December 31, 2018.  All dollar amounts are presented in Canadian dollars unless otherwise stated.
Apr 11, 2019 08:55 am ET
Kneat to Present at Bloom Burton & Co. Healthcare Investor Conference
HALIFAX, April 11, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") announced today that it will be presenting at the 2019 Bloom Burton & Co. Healthcare Investor Conference. 
Mar 11, 2019 06:47 am ET
Kneat Signs Global Biotechnology Leader
HALIFAX, March 11, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that an international leader in biotechnology has chosen Kneat's software platform to facilitate its transition to paperless validation processes.  With over 20,000 employees globally and manufacturing facilities in four continents, this company develops innovative therapies for patients around the world.  Kneat's platform will initially be launched for facilities, utilities and equipment commissioning and qualification ("C&Q") at a manufacturing plant in the United States.
Feb 21, 2019 07:21 am ET
Kneat and HCL Technologies Partner to Deliver Digital Validation Solutions to Life Sciences
HALIFAX, Feb. 21, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a partnership agreement with HCL Technologies ("HCL"), a leading global technology company, to provide innovative end-to-end digital validation solutions to customers in the life sciences industry.  HCL has an impressive network and track record within this industry; having decades of experience servicing many of the top bio-pharmaceutical, medical device, contract research, and contract development and manufacturing organizations in the world. 
Feb 20, 2019 08:00 am ET
Kneat Announces Closing of $6,339,375 Public Equity Financing and Concurrent $2,178,159 Non-Brokered Private Placement Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 14, 2019 06:03 am ET
Recently Signed Customer Scales Kneat's platform to Second Site
HALIFAX, Feb. 14, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that a top tier global healthcare customer is expanding their use of the Kneat platform to a new manufacturing site.  This customer was signed in July 2018, went live at their primary European site in December 2018 and is now expanding to a second site located in the United States.     
Feb 13, 2019 07:45 am ET
Kneat announces customer expansion at flagship US site and provides financing update
HALIFAX, Feb. 13, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that a leading laboratory services customer is expanding its user base on the Kneat platform within its flagship site in the United States.  This expansion will double the customer's license numbers.  This customer first implemented the Kneat platform in December 2018 with the ultimate goal of creating a standardized, compliant and automated equipment and instrument validation process globally.  The new licenses will be rolled out immediately.
Feb 07, 2019 08:40 am ET
IIROC Trading Resumption - KSI
VANCOUVER, Feb. 7, 2019 /CNW/ - Trading resumes in:
Feb 07, 2019 08:34 am ET
Kneat Announces Overnight Marketed Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 06, 2019 02:56 pm ET
Kneat Announces Overnight Marketed Equity Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/      
Feb 06, 2019 02:28 pm ET
IIROC Trading Halt - KSI
VANCOUVER, Feb 6, 2019 /CNW/ - The following issues have been halted by IIROC:
Dec 20, 2018 04:53 pm ET
Kneat Expands Within Life Sciences Supply Chain
HALIFAX, Dec. 20, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a master service agreement with a new customer in the life sciences supply chain. This multi-national customer provides sample lifecycle and logistics management, infrastructure and consumables, including cold storage of biological assets, to global pharmaceutical companies and will now use Kneat's software to automate and simplify their validation processes in the delivery of these services. Kneat's software as a service ("SaaS") platform will initially support this customer's grow
Nov 27, 2018 07:19 pm ET
Kneat Reports Third Quarter Results
HALIFAX, Nov. 27, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") today announced its third quarter financial results for the period ended September 30, 2018. All dollar amounts are presented in Canadian dollars unless otherwise stated.
Nov 14, 2018 07:22 am ET
Kneat signs top tier global logistics supplier
HALIFAX, Nov. 14, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce it has signed a multi-year, global contract with one of the largest logistics suppliers in the world. This new customer will implement Kneat's software as a service ('SaaS') platform to enable a compliant, paperless process for its computer systems validation ("CSV") activities in the life sciences industry. Kneat's software supports Pharmaceutical Good Distribution and Manufacturing Practices ("GDP and GMP") regulations to validate all computer systems used within our customer's life sciences operati
Aug 22, 2018 08:19 am ET
Tier One Customer Scaling Kneat's Platform to New Processes
HALIFAX, Aug. 22, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that another of its tier one pharmaceutical customers is expanding their use of Kneat's software platform. The first contract with this customer was announced in February 2018. 
Jul 23, 2018 05:08 pm ET
Kneat Customer Purchases Additional Licenses
HALIFAX, July 23, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that one of its customers has further expanded its user base of the Kneat Gx platform by purchasing additional on-premise licenses. This order represents a twenty-eight percent increase in licenses purchased and it follows a fifty percent expansion which occurred earlier in the year. Our customer, a leader in molecular diagnostics, is utilizing Kneat Gx to manage its paperless computer system validation and change management processes.  Kneat's platform is easily scaled to multiple processes and plant
Jul 16, 2018 05:31 pm ET
Multinational Pharmaceutical Manufacturer selects Kneat
HALIFAX, July 16, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it will be deploying its Software as a Service ("SaaS") platform for the biotechnology division of a multinational pharmaceutical manufacturer with more than 70 manufacturing sites worldwide. This division has purchased licenses to digitize and streamline their facilities, utilities and equipment validation processes. The initial deployment is designed to demonstrate the benefits of digitizing this division's validation process which is expected to expand to other divisions within the company.
Jul 12, 2018 07:28 am ET
Kneat Contracts with Global Healthcare Company
HALIFAX, July 12, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce its fourth new top tier customer win of 2018. One of the world's leading research-based developers of pharmaceuticals has chosen Kneat's technology to digitize its commissioning, qualification and validation processes. After historically using paper-based processes, this customer is transitioning to 100% digital to enable consistency, visibility and data integrity across its manufacturing sites. The initial scope of this on-premise license and maintenance agreement is for global capital projects with
Jun 14, 2018 08:49 am ET
A Leading Global Biotech Selects Kneat
HALIFAX, June 14, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce a new customer win.  This customer, a global leader in biotechnology, is deploying Kneat's software to a number of their sites after successfully completing product trials at an initial test site.  The customer will utilize our software for both capital and operational validation projects during the next phase of their rollout.  This customer, with an estimated 20,000 employees working across multiple sites, will transition their existing paper based validation process to one that is completely digita
Apr 10, 2018 05:10 pm ET
kneat.com Announces Closing of $6.185 Million Brokered Private Placement
HALIFAX, April 10, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company") is pleased to announce that it has closed its previously announced brokered private placement for aggregate gross proceeds of $ $6,184,647 (the "Offering"), which was increased from the previously announced amount of $5 million due to investor demand.  Through a syndicate of agents led by Echelon Wealth Partners Inc., and including Bloom Burton Securities Inc. and Industrial Alliance Securities Inc. (together, the "Agents"), the Company issued 6,871,830 common shares at an issue price of $0.90 per common s
Mar 27, 2018 12:11 pm ET
Kneat Announces Expansion of Sales Team in the United States
HALIFAX, March 27, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company") announces the appointment of Mr. Camilo Ruan as Director of Sales for the western region of the United States. Mr. Ruan has considerable experience selling enterprise software and will focus his efforts on a region where Kneat sees strong market potential for its validation lifecycle management software. 
Mar 12, 2018 09:59 am ET
IIROC Trading Resumption - KSI
VANCOUVER, March 12, 2018 /CNW/ - Trading resumes in:
Mar 12, 2018 09:43 am ET
kneat.com announces $5 million brokered private placement
HALIFAX, March 12, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company") is pleased to announce that it intends to complete a brokered private placement for aggregate gross proceeds of up to $5.0 million (the "Offering"). The Company intends to issue 5,555,556 common shares at an issue price of $0.90 per common share. The Offering will be completed through a syndicate of agents to be led by Echelon Wealth Partners Inc. (the "Agents") in which the Agents will raise up to approximately $5.0 million on a commercially reasonable best efforts basis at a price of $0.90 per common sha
Mar 12, 2018 09:42 am ET
IIROC Trading Halt - KSI
VANCOUVER, March 12, 2018 /CNW/ - The following issues have been halted by IIROC:
Feb 26, 2018 03:23 pm ET
Leading Contract Laboratory Services Company selects Kneat for its Validation Life Cycle Management
HALIFAX, Feb. 26, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("kneat.com", "Kneat", or the "Company") is pleased to announce that a leader in laboratory services to the life sciences industry has selected the Kneat platform to streamline and automate its equipment and instrumentation validation processes. The customer's goal is to convert to an end-to-end paperless process that enhances compliance, increases productivity and enables greater transparency and control. The initial deployment will be at one of its flagship laboratories in the United States which has more than 1,000 employees focus
Feb 15, 2018 08:00 am ET
Tier 1 Pharmaceutical Manufacturer Selects Kneat's SaaS platform
HALIFAX, Feb. 15, 2018 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("kneat.com", "Kneat", or the "Company") is pleased to announce that a leading Tier 1 pharmaceutical company, headquartered in the United States and with over thirty manufacturing and laboratory sites globally, has selected Kneat. Kneat's software platform will replace the client's paper-based commissioning and qualification ("C&Q") process with one that is end-to-end paperless. Our new client is seeking to improve data integrity and productivity by implementing a structured C&Q process that can be leveraged globally across
Jan 19, 2018 05:49 am ET
Molecular diagnostics leader expands Kneat further across its operations
HALIFAX, Jan. 19, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) ("kneat.com", "Kneat", or the "Company") is pleased to announce that one of its customers, a leading US molecular diagnostics company, has increased its number of Kneat licenses by fifty percent. This growth is in response to the customer's desire to scale Kneat to a wider global workforce and is confirmation of the value Kneat's software continues to deliver for this key customer. 
Sep 18, 2017 06:24 pm ET
Published Case Study: Global Biotech deploys Kneat for Laboratory Asset Lifecycle Management across all its global laboratories, supporting their lab of the future vision
HALIFAX, Sept. 18, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company"), announces that it has partnered with a key customer to publish a case study entitled "Newly optimized Laboratory Asset Lifecycle Management System supports QC Laboratory of the Future" which is published in The Parental Drug Association ("PDA") Letter.  
Aug 30, 2017 07:57 pm ET
Published Case Study: Kneat enables Validation Process Innovation at pioneering Molecular Diagnostics Company
HALIFAX, Aug. 30, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company"), is pleased to announce that the case study entitled "Validation Process Innovation in Molecular Diagnostics" was published today in the Journal of Validation Technology.
Aug 21, 2017 10:15 am ET
kneat.com, inc. announces the passing of director James Osborne
HALIFAX, Aug. 21, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company"), sadly announces that Mr. James Osborne, a director of the Company, recently passed away. Mr. Osborne has been a key member of the Kneat team and played an instrumental role in the transaction resulting in the public listing of Kneat Solutions Limited in 2016.
Jun 14, 2017 05:17 pm ET
kneat.com, inc. provides a corporate update
HALIFAX, June 14, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company"), developer of the next generation Kneat Gx platform for regulated industries, is pleased to provide a corporate update outlining Kneat's key accomplishments since completing a public listing on the Canadian TSX Venture Exchange on July 5, 2016.
May 31, 2017 05:15 pm ET
kneat.com, inc. announces the closing of private placement
HALIFAX, May 31, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company"), developer of the next generation Kneat Gx platform for regulated industries, today closed its previously announced non-brokered private placement for aggregate gross proceeds of $3,000,000 (the "Offering"). The Company issued 5,000,000 common shares at an issue price of $0.60 per share. The common shares issued in connection with the private placement are subject to a four-month hold period that will expire on October 1, 2017. Directors of the Company subscribed for an aggregate of 1,175,066 common shares.
May 10, 2017 06:00 pm ET
kneat.com, inc. to complete non-brokered private placement
HALIFAX, May 10, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company"), the developer of the next generation Kneat.Gx platform for regulated industries, is pleased to announce that it intends to complete a non-brokered private placement for an estimated aggregate gross proceeds of $3,000,000 (the "Offering"). The Company intends to issue an estimated 5,000,000 common shares at an issue price of $0.60 per share.
Apr 03, 2017 04:42 pm ET
Kneat announces appointment of United States sales director
HALIFAX, April 3, 2017 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat" or the "Company") today announces the appointment of Mr. Derek Hughes in the role of United States Sales Director. Mr. Hughes will be responsible for sales of the Kneat.Gx software platform throughout the United States.  Mr. Hughes joins the Kneat team after having spent the past six years successfully selling and promoting regulated software technologies into the life sciences industry throughout the United States.
Feb 22, 2017 05:16 pm ET
Journal of Validation Technology publishes industry case study outlining efficiencies enabled by Kneat software
HALIFAX, Feb. 22, 2017 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("kneat.com", "Kneat", or the "Company") today announced that the Journal of Validation Technology published the article 'Case Study: Implementation of an Electronic Life Cycle Management System for Validation ….and Beyond' which outlines the value of the Kneat Gx software.
Jan 04, 2017 08:07 pm ET
Multi-National Pharmaceutical Company Deploys Kneat's E-Validation Platform Across All Sites
HALIFAX, Jan. 4, 2017 /CNW/ - kneat.com, inc. (TSXV: KSI) ("kneat.com", "Kneat", or the "Company") is pleased to announce that a large multi-national pharmaceutical company has deployed the Kneat Gx platform to replace many of its paper-based validation and GxP testing processes within their highly regulated manufacturing facilities world wide. The Kneat Gx platform provides a compliant e-validation solution that enables life science companies to become efficient and compliant with an automated process that has traditionally been manual, in-efficient and paper-based. Our customer is reportin
Nov 03, 2016 10:45 am ET
Kneat Announces Appointment of European Sales Director
HALIFAX, Nov. 3, 2016 /CNW/ - kneat.com, inc. (TSXV: KSI) ("kneat.com", "Kneat" or the "Company") is pleased to announce the appointment of Mr. Mark Geldard as its European Sales Director. Mr. Geldard will lead the Company's sales and marketing activities throughout Europe.  With over 23 years of experience in sales, marketing and business development within the software and IT services industry, Mr. Geldard is ideally suited for this position. Most recently he held the position of Senior Account Manager Life Sciences at NNIT A/S in Zurich, Switzerland.